Table 1. Baseline clinical and demographic characteristics of enrolled patients (n = 26).
Characteristic | Patients (n = 26) | |
No | % | |
TSER genotypes | ||
TSER*2/*2 | 5 | 19 |
TSER*2/*3 | 21 | 81 |
Gender | ||
Male | 16 | 62 |
Female | 10 | 38 |
Age (years) | ||
median | 56 | |
range | 26–81 | |
Ethnicity | ||
Caucasians | 23 | 88 |
African Americans | 2 | 8 |
Not reported | 1 | 4 |
ECOG performance status | ||
0 | 5 | 19 |
1 | 13 | 50 |
2 | 8 | 31 |
Primary tumor type | ||
Gastric | 19 | 73 |
Gastroesophageal junction (GEJ) | 7 | 27 |
Prior neoadjuvant or adjuvant therapy (>6 months) | 2 | 8 |